Cytox
Cytox is developing transformational prognostic technology that may contribute to the assessment of an individual's risk of developing
Cytox has raised €2.1M across 1 funding round from 1 investor, most recently a round in Apr 2014. Based in Manchester, UK; founded 2007. Data as of 28 Oct 2026.
Manchester, UKFounded 2007
Total raised
€2.1M
€2,085,000
Funding rounds
1
Investors
1
distinct backers
Active since
2014-04
latest 2014-04
Funding by year
EUR raised per yearCytox — funding by year — interactive chart.
Data table
| Cytox — funding by year | |
|---|---|
| 2014 | €2.1M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-04-01 | Other | €2.1M | Midven | View deal → |